Nektar Therapeutics Company

Nektar Therapeutics develops therapeutics based on its advanced polymer conjugate chemistry technology platform.
Technology: Biotechnology, CAR-T therapy, Cell therapy, Chemical, Health Care, Therapeutics
Industry: Pharma, Public
Headquarters: San Carlos, California, United States
Founded Date: 1990-01-01
Employees Number: 501-1000
Funding Status: IPO
Acquisitions Number: 2
Investors Number: 4
Total Funding: 1169999960
Estimated Revenue: $50M to $100M
Last Funding Date: 2021-02-17
Last Funding Type: Post-IPO Equity

Visit Website
NektarSC@nektar.com
http://twitter.com/NektarNews
Register and Claim Ownership